IRONWOOD PHARMACEUTICALS INC·4

Jan 22, 4:38 PM ET

John Minardo 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Jan 22, 2025

Insider Transaction Report

Form 4
Period: 2025-01-17
John Minardo
Chief Legal Officer
Transactions
  • Award

    Class A Common Stock

    2025-01-17+40,187324,848 total
Footnotes (1)
  • [F1]Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 2, 2022. The earned PSUs were certified and vested on January 17, 2025.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4